Paper Details 
Original Abstract of the Article :
AIM: Losartan and antiplatelet agent ticlopidine can be prescribed concomitantly for prevention or therapy of cardiovascular diseases. Hence, the effects of ticlopidine on the pharmacokinetics of losartan and its active metabolite EXP-3174 were evaluated in rats. METHODS: Ticlopidine (4 or 10 mg/kg...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003123/

データ提供:米国国立医学図書館(NLM)

Ticlopidine and Losartan: A Tale of Two Drugs and Their Unexpected Interaction

The realm of cardiovascular health is a complex and intricate one, involving the interaction of various medications and their impact on different bodily systems. This study delves into the fascinating world of drug interactions, examining the effect of ticlopidine, an antiplatelet agent, on the pharmacokinetics of losartan, a medication used to manage high blood pressure. The researchers sought to unravel the intricate relationship between these two drugs, understanding how their combined presence affects the body's processing and elimination of each medication.

The study involved administering ticlopidine and losartan to rats and carefully observing the resulting changes in blood concentrations of both drugs. The researchers investigated the role of specific enzymes, known as CYP2C9 and 3A4, and a transporter protein called P-gp, in metabolizing and transporting these medications. By studying the effects of ticlopidine on these processes, the researchers aimed to identify the key factors influencing the pharmacokinetics of losartan.

Ticlopidine and Losartan: A Complex Dance of Drug Interactions

The study revealed that ticlopidine significantly increased the levels of losartan in the blood, suggesting a potential interaction between these two drugs. This finding is crucial for healthcare professionals, as it highlights the importance of considering drug interactions when prescribing medications. The study identified the inhibition of certain enzymes, particularly CYP2C9 and 3A4, as the primary mechanism behind the increased levels of losartan.

Navigating the Desert of Drug Interactions: A Guide for Healthcare Professionals

This study provides valuable insights into the complex world of drug interactions, serving as a reminder for healthcare professionals to remain vigilant in their prescription practices. Just as a camel navigating a desert landscape must be aware of potential obstacles, healthcare providers must be mindful of the potential for interactions between medications. By considering the potential for interactions, healthcare professionals can optimize patient safety and ensure the best possible treatment outcomes.

Dr. Camel's Conclusion

This study underscores the crucial role of pharmacokinetic research in understanding the intricate relationship between drugs and the human body. Just as a camel adapts to the harsh conditions of the desert, healthcare professionals must be adaptable and informed in their approach to managing drug interactions, ensuring patient safety and well-being.

Date :
  1. Date Completed 2011-10-24
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

21666702

DOI: Digital Object Identifier

PMC4003123

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.